Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Products>This Product

Fluidic Connect PRO - microfluidic chips connected fast, easy and robust

Product Image
Product Description

The brand new Fluidic Connect PRO chipholder makes connecting your microfluidic components to the outside world faster and easier than ever before. The innovative Load 'n' Seal technique assures leak-tight connections without the possibility of breaking your microfluidic chips. By cleverly making the use of inserts the holder can easily be adapted to chips of different sizes, thicknesses and functionalities. Multiple chips can even be connected fluidically and electrically at the same time. This easy usage also makes it an ideal component to integrate into your devices.

The Load 'n Seal design assures tight connections without the
possibility of breaking precious microfluidic chips. By cleverly
making use of inserts the holder can easily be adapted to chips of
different sizes and thicknesses. It is even capable of connecting
multiple chips at one time.

Special Features:

• Fast, easy, and robust fluidic connections
• Future proof thanks to replaceable inserts
• Holder defined sealing to prevent chip cracking
• Simultaneous connection of multiple chips
• Large chip viewing area possible
• Compatible with upright and inverted microscopes
• Suitable for resealable flowcells
• Able to connect chips from 15 x 15 mm up to 30 x 90 mm

Product Fluidic Connect PRO - microfluidic chips connected fast, easy and robust
Company Micronit Microfluidics B.V.
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Micronit Microfluidics B.V.
Colosseum 15 7521 PV Enschede The Netherlands

Tel: +31 53 850 6 850
Fax: +31 53 850 6 851

Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Promising Drug Combination for Advanced Prostate Cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
A Cellular Symphony Responsible for Autoimmune Disease
Broad Institute researchers have used a novel approach to increase our understanding of the immune system as a whole.
When it Comes to Breast Cancer, Common Pigeon is No Bird Brain
If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing digitized microscope slides and mammograms of normal vs. cancerous breast tissue, a new study has found.
Editing of LIMS Data Made Faster and More Efficient in Matrix Gemini
The latest version of the Matrix Gemini LIMS (Laboratory Information Management System) from Autoscribe Informatics now provides faster and more efficient editing of LIMS data by eliminating the need for a second editing screen.
University of Edinburgh, Selcia Achieve Key Milestones in Drug Development Program
Scientists from the University of Edinburgh, working with Selcia, have successfully passed the 20-month milestone targets of a 30-month Wellcome Trust SDDi £2.5 million project to design novel treatments for sleeping sickness.
Red Clover Genome to Help Restore Sustainable Farming
The Genome Analysis Centre (TGAC) in collaboration with IBERS, has sequenced and assembled the DNA of red clover to help breeders improve the beneficial traits of this important forage crop.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
Scroll Up
Scroll Down

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos